1h Free Analyst Time
The rheumatoid arthritis diagnostic devices market is forecasted to grow by USD 115.9 million during 2023-2028, accelerating at a CAGR of 4.51% during the forecast period. The report on the rheumatoid arthritis diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing number of rheumatoid arthritis cases, availability of improved diagnostic modalities, and lucrative opportunities in emerging economies.
The rheumatoid arthritis diagnostic devices market is segmented as below:
By Product
- Analyzers
- Consumables
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the rheumatoid arthritis diagnostic devices market covers the following areas:
- Rheumatoid arthritis diagnostic devices market sizing
- Rheumatoid arthritis diagnostic devices market forecast
- Rheumatoid arthritis diagnostic devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global rheumatoid arthritis diagnostic devices market: Abbott Laboratories, Antibodies Inc., Augurex Life Sciences Corp., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Danaher Corp., DNAlytics SA, EUROBIO SCIENTIFIC, F. Hoffmann La Roche Ltd., Myriad Genetics Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing number of business strategies."
According to the report, one of the major drivers for this market is the increasing number of rheumatoid arthritis cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Antibodies Inc.
- Augurex Life Sciences Corp.
- Aviva Systems Biology Corp.
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Dnalytics Sa
- Eurobio Scientific
- F. Hoffmann La Roche Ltd.
- Myriad Genetics Inc.
- Qiagen Nv
- Quest Diagnostics Inc.
- Siemens AG
- Svar Life Science Ab
- Thermo Fisher Scientific Inc.
- Werfenlife Sa
